Cognition Therapeutics Inc. Gains 28.5%
Cognition Therapeutics Inc. (CGTX:NASDAQ) jumped higher at $2.48, a gain of 28.5%. On Fri, Nov 25, 2022, CGTX:NASDAQ touched a New 2-Week High of $2.48. The stock got featured on our News Catalysts scanner on Mon, Nov 21, 2022 at 08:25 AM in the 'MISCELLANEOUS' category. From Mon, Nov 14, 2022, the stock recorded 75.00% Up Days and 55.56% Green Days
The stock spiked on Thu, Aug 04, 2022 at $6.27 with a volume of 21M+.
About Cognition Therapeutics Inc. (CGTX:NASDAQ)
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative...
Top 10 Gainers:
- FedNat Holding Company (FNHC:NASDAQ), 94.71%
- AEye Inc. (LIDR:NASDAQ), 50.02%
- Euda Health Holdings Ltd Ord Shs (EUDA:NASDAQ), 37.04%
- Peak Bio Inc Com (PKBO:NASDAQ), 36.84%
- Kidpik Corp. (PIK:NASDAQ), 36.75%
- Expion360 Inc. (XPON:NASDAQ), 36.1%
- VEON Ltd. (VEON:NASDAQ), 31.14%
- Vapotherm, Inc. (VAPO:NYSE), 30.18%
- Cognition Therapeutics Inc. (CGTX:NASDAQ), 28.5%
- Super League Gaming, Inc. (SLGG:NASDAQ), 24.27%